Accession Number: | 0001209191-21-004142 |
Date: | 2021-01-15 |
Issuer: | ADVERUM BIOTECHNOLOGIES, INC. (ADVM) |
Original Submission Date: |
FISCHER LAURENT
C/O ADVERUM BIOTECHNOLOGIES, INC.
800 SAGINAW DRIVE
REDWOOD CITY, CA 94063
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-01-15 | P | 8,600 | a | $11.53 | 16,292 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | price reported is a weighted-average purchase price. the shares were purchased at prices ranging from $11.44 to $11.60. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. |